As Merck and Pfizer prepare to report clinical demo benefits for experimental COVID-19 antiviral supplements, rivals are lining up with what they hope will prove to be far more strong and effortless oral treatments of their have. Enanta Pharmaceuticals, Pardes Biosciences, Japan’s Shionogi and Novartis reported they have intended antivirals […]
Trending Tags
Saturday, May 24, 2025